1 |
tumor necrosis factor-alpha
(41538 times)
|
Allergy and Immunology (6198 times)
|
IL-6 (6349 times) IL-1beta (5271 times) LPS (4917 times)
|
0 Tumor Necrosis Factor Alpha Signaling in Trigeminal Ganglion Contributes to Mechanical Hypersensitivity in Masseter Muscle During Temporomandibular Joint Inflammation.
|
2 |
alpha-tumor necrosis factor
(8 times)
|
Obstetrics (3 times)
|
IL-1beta (2 times) AM (1 time) BAL (1 time)
|
2000 Effects of nickel sulfate on pulmonary natural immunity in Wistar rats.
|
3 |
transforming necrosis factor alpha
(5 times)
|
Allergy and Immunology (2 times)
|
CRP (1 time) ELISA (1 time) ICAM-I (1 time)
|
1999 Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes.
|
4 |
Tumor necrosis factor-alpha/cachectin
(5 times)
|
Allergy and Immunology (2 times)
|
anti-hTNF-alpha (1 time) Bo rIFN-gamma (1 time) BP (1 time)
|
1987 Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells.
|
5 |
transforming growth factor-alpha
(4 times)
|
Biochemistry (2 times)
|
COX-2 (2 times) IL-6 (2 times) CM (1 time)
|
2008 Accelerated Ulcer Healing and Resistance to Ulcer Recurrence with Gastroprotectants in Rat Model of Acetic Acid-induced Gastric Ulcer.
|
6 |
tumor necrosis factor receptor-alpha
(3 times)
|
Science (1 time)
|
eNOS (1 time) HE (1 time) HUVECs (1 time)
|
1997 Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
|
7 |
tumor necrosis growth factor-alpha
(3 times)
|
Immune System (1 time)
|
bFGF (2 times) HGF (2 times) VEGF (2 times)
|
2000 Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.
|
8 |
Treated with Antitumor Necrosis Factor-Alpha
(2 times)
|
Medicine (1 time)
|
---
|
2014 Anti-TNF-alpha and risk of infections: the experience in one center.
|
9 |
tumor nuclear factor-alpha
(2 times)
|
Parasitology (1 time)
|
CRP (1 time) CVD (1 time) IL (1 time)
|
2010 Leishmanicidal activity of Himatanthus sucuuba latex against Leishmania amazonensis.
|
10 |
Anti-Tnf-alpha/FNAB/PC-Au for protein biomarker
(1 time)
|
Biotechnology (1 time)
|
FNAB (1 time) PBS-T20 (1 time) PC (1 time)
|
2017 On-chip electrochemical immunoassay platform for specific protein biomarker estimation in undiluted serum using off-surface membrane matrix.
|
11 |
inflammation-tumor necrosis factor-alpha
(1 time)
|
Endocrinology (1 time)
|
BMI (1 time) CV (1 time) hs-CRP (1 time)
|
2015 Obesity, but not polycystic ovary syndrome, affects circulating markers of low-grade inflammation in young women without major cardiovascular risk factors.
|
12 |
non-smokers.Tumor necrosis factor-alpha
(1 time)
|
Pulmonary Medicine (1 time)
|
BAL (1 time) COPD (1 time) IL-6 (1 time)
|
2014 Compartment differences of inflammatory activity in chronic obstructive pulmonary disease.
|
13 |
production--tumour necrosis factor-alpha
(1 time)
|
Virology (1 time)
|
EIAV (1 time) HIV (1 time) IFN-alpha (1 time)
|
1997 Elevation of cytokines associated with the thrombocytopenia of equine infectious anaemia.
|
14 |
T cell, could activate neither macrophage production of inflammatory cytokines
(1 time)
|
Allergy and Immunology (1 time)
|
---
|
1996 Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice.
|
15 |
thymus and spleen weights as well as serum necrosis factor-alpha
(1 time)
|
Biochemistry (1 time)
|
IL-2 (1 time) MW (1 time) Se (1 time)
|
2016 Anti-tumor and immunomodulatory activity of selenium (Se)-polysaccharide from Se-enriched Grifola frondosa.
|
16 |
treatment strategies for Crohn's disease including antitumor necrosis factor-alpha
(1 time)
|
Pediatrics (1 time)
|
GH (1 time) IGF (1 time) IL-6 (1 time)
|
2011 The role of growth hormone and insulin-like growth factor-1 in Crohn's disease: implications for therapeutic use of human growth hormone in pediatric patients.
|
17 |
tube dilution method, lymphocyte proliferation, and pro-inflammatory cytokines
(1 time)
|
Pharmacology (1 time)
|
---
|
2015 Immunosuppressive potential of Botryosphaeria dothidea, an endophyte isolated from Kigelia africana.
|
18 |
tumor necreactive oxygen speciesis factor-alpha
(1 time)
|
Pharmacology (1 time)
|
AD (1 time) COX-2 (1 time) GCLM (1 time)
|
2017 L-F001, a novel multifunctional ROCK inhibitor, suppresses neuroinflammation in vitro and in vivo: Involvement of NF-kappaB inhibition and Nrf2 pathway activation.
|
19 |
tumor necrosis alpha-factor
(1 time)
|
Medicine (1 time)
|
---
|
1996 [Correlation between histocompatibility antigens, tumor necrosis factor-alpha, and HIV infection].
|
20 |
tumor necrosis factor-alpha expression
(1 time)
|
Biochemistry (1 time)
|
IL-1 (1 time)
|
1997 Interleukin-1 stimulates tumor necrosis factor-alpha (TNF-alpha) release from cytotrophoblastic BeWo cells independently of induction of the TNF-alpha mRNA.
|
21 |
Tumor Necrosis Factor-alpha serum concentration
(1 time)
|
Biology (1 time)
|
---
|
1996 Evolution of tumor necrosis factor-alpha serum concentrations in HIV infected individuals treated with zidovudine.
|
22 |
tumour necrosis factor-alpha production
(1 time)
|
Cell Biology (1 time)
|
IA (1 time)
|
2018 Neutrophils differentially attenuate immune response to Aspergillus infection through complement receptor 3 and induction of myeloperoxidase.
|
23 |
type and number of infiltrating cells, changes in protein, cytokine
(1 time)
|
Dermatology (1 time)
|
DNFB (1 time) EGFRIs (1 time) SCF (1 time)
|
2011 Phenylbutyrate suppresses distinct skin reactions that are enhanced by blockade of epidermal growth factor receptor signaling.
|